AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2021

Aug 13, 2021

30870_dirs_2021-08-13_6ce2030c-3539-44ca-ae3e-bc36d0fbe74e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-08-12

Reporting Person: Malik Fady Ibraham (EVP Research & Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-12	Common Stock	S	2000	$32.6	Disposed	154878	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on March 31, 2020.

F2: Includes 2,000 shares of common stock purchased pursuant to the Issuer's 2015 Employee Stock Purchase Plan (ESPP).